Navigation Links
Researchers attack tumor cells by exploiting dependency on sugar metabolism

Although scientists have known for nearly 90 years that cancer cells commonly display altered sugar metabolism, the molecular significance of this phenomenon is not completely understood. Now, a new study published in the June issue of Cancer Cell reveals a functional connection between carbohydrate-driven energy production and tumor maintenance. Importantly, the results suggest that inhibition of a specific aspect of glucose metabolism may represent an attractive and potentially well-tolerated approach to interfering with tumor growth.

Normal cells produce most of the ATP they need to power cellular functions through an oxygen-dependent process known as oxidative phosphorylation. In contrast, cancer cells commonly switch to what is known as a "glycolytic phenotype," producing ATP through a process that can occur in the absence of oxygen and involves conversion of glucose to lactate. Scientists believe that the glycolytic phenotype enables rapidly proliferating tumor cells to survive even when environmental oxygen levels are not optimal. In addition, perturbations of the normal physiology of mitochondria, cellular structures involved in oxygen-dependent ATP production, have also been linked to cancer.

Dr. Valeria Fantin, formerly of the Department of Genetics at Harvard Medical School, and colleagues examined whether blocking the conversion of glucose to lactate in mammary tumor cells might help shed light on the association between tumor survival and the interplay between glycolytic phenotype and mitochondrial metabolism. The researchers used a sophisticated genetic technique to reduce levels of lactate dehydrogenase A (LDH-A), an enzyme required for the glucose to lactate pathway that is elevated in human breast and lung cancers. Inhibition of LDH-A stimulated mitochondrial function and drastically compromised the ability of the tumor cells to proliferate in low oxygen conditions. Restoration of LDH-A activity reestablished the glycolytic phenotyp e of the tumor cells.

These data suggest that alterations in glucose metabolism in cancer cells are linked with changes in mitochondrial physiology and that LDH-A plays a critical role in tumor growth. The researchers propose that inhibition of LDH-A may represent a rational and safe strategy for treatment of cancer. "Because individuals with complete hereditary deficiency of LDH-A do not show any symptoms under ordinary circumstances, the genetic data suggest that inhibition of LDH-A activity may represent a relatively nontoxic approach to interfere with tumor growth," explains Dr. Fantin.


'"/>

Source:Cell Press


Related biology news :

1. Researchers discover way to make cells in the eye sensitive to light
2. Researchers find how protein allows insects to detect and respond to pheromones
3. Researchers Uncover Key Step In Manufacture of Memory Protein
4. Researchers reveal the infectious impact of salmon farms on wild salmon
5. Researchers identify target for cancer drugs
6. Researchers discover molecule that causes secondary stroke
7. Researchers find missing genes of ancient organism
8. Researchers trace evolution to relatively simple genetic changes
9. Researchers add new tool to tumor-treatment arsenal
10. UF Researchers Map Bacterial Proteins That Cause Tooth Loss
11. VCU Researchers Identify Networks Of Genes Responding To Alcohol In The Brain
Post Your Comments:
*Name:
*Comment:
*Email:


(Date:12/5/2018)... Tenn. (PRWEB) , ... December 05, 2018 , ... ... at the Annual AANS/CNS Summit in Nashville, TN, from December 6-9, 2018 at ... Virtual Reality platform that seamlessly integrates throughout the treatment continuum – from the ...
(Date:12/5/2018)... ... 2018 , ... Slone Partners, North America’s leading executive search ... at Karius, Inc. as Chief Commercial Officer. Now responsible for developing, executing, and ... in Redwood City, California and report to CEO Mickey Kertesz Ph.D. , ...
(Date:12/5/2018)... DIEGO (PRWEB) , ... December 04, 2018 , ... ... leverage Fastec’s extensive expertise and existing IP in the development of innovative solutions ... has been integrated into diverse systems from microfluidics to industrial machinery and instrumentation, ...
Breaking Biology News(10 mins):
(Date:11/13/2018)... ... 13, 2018 , ... Aditya Humad, Managing Partner of ... asserts it is still trending upward with growing valuations based on a largely ... consolidation, pricing pressure and increased competition as reasons often cited by institutional investors ...
(Date:11/11/2018)... ... ... Triple W, an innovator of connected health devices, today announced that it ... ®, the first health tech wearable device for incontinence that monitors how full your ... announcement was made during CES Unveiled New York, an invite-only tech event bringing together ...
(Date:11/9/2018)... ... November 08, 2018 , ... Superior ... and IT solutions with 140 employees on both the east and west coasts, ... the Pennsylvania Convention Center on November 14 and 15 in Philadelphia. The event ...
(Date:11/6/2018)... ... November 06, 2018 , ... ... for clinical trial data collection and management. TrialKit ™, an eClinical platform, ... generation devices can quickly and easily sign in to the app via facial ...
Breaking Biology Technology: